Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1408_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
10 Мб
Скачать
☆
Index
Note: Page numbers followed by f indicate figures and t indicate tables.
A
AAF. See Anal advancement flap (AAF) AAST. See American Association for the Surgery
of Trauma (AAST)
Abscess
anorectal (see Anorectal abscess) perianal, in Crohn’s disease, 142–147
diagnosis of, 145 imaging of, 145–146
treatment for, 146–147 Acellular dermal matrix (ADM), 94 Acellular extracellular matrix (AEM), 94 Adalimumab, for perianal abscess and fistula
in Crohn’s disease, 146
Adipose-derived stem cells (ASC)
for anorectal abscess, 94
for anorectal fistula, 94 ADM. See Acellular dermal matrix (ADM) Advanced Trauma Life Support (ATLS),
208–210
Advancement flap
for anorectal abscess, 91–92, 92f
for anorectal fistula, 91–92, 92f AEM. See Acellular extracellular matrix (AEM) AFP. See Anal fistula plug (AFP) AGA. See American Gastroenterological
Association (AGA) Albendazole, for pinworm pruritus, 121 Altemeier operation, 255 Amebiasis, 132–133 American Association for the Surgery of
Trauma (AAST)
rectal injury grading system of hematoma,
208t American Gastroenterological Association
(AGA)
classification of perianal fistula, 144, 144t
Amitriptyline, for fecal incontinence, 171
Amussat, 29 Anal adenocarcinoma, 193 Anal advancement flap (AAF), for anal fissure,
75–76 Anal basal cell carcinoma, 196 Anal Buschke-Loewenstein tumor, 192 Anal carcinogenesis, 190–191 Anal-closure mechanism
anal-closure mechanism, functional
assessment of, 24–25, 24f
functional assessment of, 24–25, 24f in humans, anatomy and function
assessment of, 21–23, 23f Anal fissure
additional investigations for, 67, 68–71f definition of, 65, 66f diagnosis of, 66
–67
etiology
of,
65–66 pathophysiology of, 65–66 practical therapeutical guideline and
work-up, 76 and pruritus ani, 119–120, 120t specific conditions, 77
human immunodeficiency virus, 77 inflammatory bowel disease, 77
lues, 77 after surgery for anorectal diseases, 253 symptoms of, 66–67 therapy for, 67–76
conservative management, 72–75
surgical management, 75–76
Anal fistula plug (AFP)
for anorectal abscess, 93 for anorectal fistula, 93
Analgesics, for hemorrhoids, 119 Anal lymphoma, 195 Anal mass sensation, 194 Anal melanoma, 194–195
265
Anal MEPs, 42 Anal mesenchymal tumors, 195–196 Anal neuroendocrine tumors, 195 Anal plugs, for fecal incontinence, 172 Anal radiofrequency, for fecal incontinence,
173 Anal sexual intercourse, 191 Anal squamous cell carcinoma (SCC), 189 Anal squamous intraepithelial lesions, 189–191 Anal stricture, following a Milligan-Morgan
operation, 252f Anal tattooing, for pruritus ani, 118 Anal tumors, 189
anal adenocarcinoma, 193 anal basal cell carcinoma, 196 anal Buschke-Loewenstein tumor, 192 anal lymphoma, 195 anal melanoma, 194–195 anal mesenchymal tumors, 195–196 anal neuroendocrine tumors, 195 anal SCC, 191–192 anal squamous intraepithelial lesions,
189–191
extramammary Paget disease, 193–194 secondary tumors (metastases), anal canal,
196 Anocutaneous reflex assessment, 32 Anodermal advancement flap, 91–92, 92f Anoplasty, for anorectal malformations,
181–183, 184f Anorectal abscess
adipose-derived stem cells, 94 classification of, 82–83, 82f clinical presentation of, 83–84 in Crohn’s disease patients, treatment for,
95–97
laser ablation for, 95 nonsphincter-preserving operation, 90–91
fistulectomy, 90 fistulotomy, 90
seton, 90–91 over-the-scope-clip, 94–95 preoperative imaging of, 85–88, 86–87f sphincter-preserving operation, 91–95, 96f
advancement flap, 91–92, 92f
anal fistula plug, 93 fibrin glue injection, 92 ligation of intersphincteric fistula tract, 93 video-assisted ablation of the fistula tract,
94
treatment for, 88–89
Anorectal anatomy and function
anal-closure mechanism in humans,
anatomy and function assessment of, 21–23, 23f
deep pelvic floor muscles (levator ani)
anatomy and function, relationship
between, 14–17, 15–19f, 19–
20
external
anal
sphincter, 11–13, 12–13f
length-tension function of, 20, 21f
internal anal sphincter, 10–11, 10f
neural control of, 11
puborectalis muscle, 14–17
length-tension function of, 20, 21f Anorectal angle, 154–156, 158 Anorectal diseases, and pruritus ani, 118–121
anal fissure, 119–120, 120t hemorrhoids, 118–119 infections, 120–121 psychological causes, 121
Anorectal disorders (ADs), diagnostic tools in,
38f anal MEPs, 42 anorectal sensory and motor function tests,
42–44
balloon distension and rectal barostat,
42–44, 43f anorectal structure tests, 42
endoanal and pelvic floor ultrasound, 42
evacuation tests, 44–45
balloon expulsion test, 44 colonic transit testing, 44–45
defecography, 45 initial approach, 38–39 motor function tests, 39–42
anorectal manometry, 39–41
anorectal neurophysiology, 41
functional lumen imaging probe, 41
translumbar MEPs, 42
transsacral MEPs, 42
266 Index
Anorectal fistula (ARF)
adipose-derived stem cells, 94 classification of, 82–83, 84f clinical presentation of, 83–84 in Crohn’s disease patients, treatment for,
95–97 laser ablation for, 95 nonsphincter-preserving operation, 90–91
fistulectomy, 90 fistulotomy, 91f
seton, 90–91, 91f over-the-scope-clip, 94–95 preoperative imaging of, 85–88, 86–87f sphincter-preserving operation, 91–95, 96f
advancement flap, 91–92, 92f
anal fistula plug, 93
fibrin glue injection, 92
ligation of intersphincteric fistula tract, 93
video-assisted ablation of the fistula
tract, 94
treatment for, 89–95
Anorectal foreign body
body packer, 207 body pusher, 207 clinical assessment of, 202–203
history taking, 202
physical examination, 202–203
radiologic evaluation, 203 epidemiology of, 201–202 ingested foreign body, 207 management of, 203–206, 206f
endoscopic removal, 204 –205
minimally invasive transanal removal, 205
operative removal, 205–206
transanal removal, 203–204 type of, 202t
Anorectal function assessment, using
meneuvers, 32–33 Anorectal junction (ARJ), 154, 156–158 Anorectal malformations
classification of, 179, 180t clinical manifestations and diagnostic
approach, 180–182, 181–182f
follow-up, 185–186 rectovestibular fistula, 179, 180f
treatment for, 183–185
medical approach, 183 surgical approach, 183–185, 184–
186f
Anor
ectal
manometry (ARM), 34–35, 218,
256–257 for evacuatory dysfunction, 40–41, 40f for fecal incontinence, 39–40, 165–167, 167f for motor function tests, 39–41
Anorectal neurophysiology, for anorectal
disorders, 41
Anorectal pain assessment, using maneuvers,
33–34
Anorectal region examination
clinical utility of DRE, 34–35 DRE protocol, 29–34, 30f, 31t
Anorectal sensory tests, 42–44
balloon distension and rectal barostat,
42–44, 43f
Anorectal structure tests, 42
endoanal and pelvic floor ultrasound, 42
Anorectal trauma/injury, 208–209
clinical assessment of, 208–209 grading system of, 208t
Anorectum, embryology of
hindgut, 2–3, 4f theories on development of hindgut, 3–6
Antegrade continence enema, for fecal
incontinence, 173
Anterograde enemas, 224 Antibiotic therapy, for anorectal abscess, 89 Anticoagulants, hemorrhoids in patients
taking, 60–61
Antiplatelet drugs, hemorrhoids in patients
taking, 54
Antiprolapse surgery, 232–233 Apoptosis, 5–6 ARF. See Anorectal fistula (ARF) Aristotle, 179 ARJ. See Anorectal junction (ARJ) ARM. See Anorectal manometry (ARM) Artificial intestinal sphincter, for fecal
incontinence, 174
ASC. See Adipose-derived stem cells (ASC) ATLS. See Advanced Trauma Life Support
(ATLS)
Index 267
Autologous adipose tissue transplantation, for
anal fissure, 76
Azathioprine, for perianal abscess and fistula
in Crohn’s disease, 146
B
Balloon distension, 42–44, 43f Balloon expulsion test (BET ), 44 Barium defecography, 45, 218 Barium enema, 231 Bascom I technique, 106, 108f Bascom II technique, 106, 110 Benign perineal teratoma, 181f BET. See Balloon expulsion test (BET) BFT. See Biofeedback therapy (BFT) Bioabsorbable synthetic fistula plug, 93 Biofeedback therapy (BFT)
for fecal incontinence, 171–172 pelvic floor retraining, 219–222
pelvic floor therapy with, for anal fissure, 72 Biologic sealant, for pilonidal disease, 111 Body packers, 207 Body pushers, 207 Body stuffing, 207 Botulinum toxin (BT), 219–222
for anal fissure, 74–75 BT. See Botulinum toxin (BT) Bucket-handle malformation, 181, 184f
C
Calcium blockers ointment, for anal fissure,
67–72
Calcium channel blockers (CCB), for anal
fissure, 74–77
Calcium dobesilate, for internal hemorrhoids,
57 Capsaicin, for pruritus ani, 117–118 Cardiff classification, of perianal disease, 139t CCB. See Calcium channel blockers (CCB) CDC. See Centers for Disease Control and
Prevention (CDC) Ceftriaxone/azithromycin, for gonorrhea, 128 Ceftriaxone, for gonorrhea, 128 Centers for Disease Control and Prevention
(CDC), STDs treatment guidelines, 127 Cervical carcinogenesis, 190–191
Chemical sphincterotomy, for anal fissure,
72–74 Chemotherapy, 192 Chronic constipation, 215–216 Chronic proctalgia (CP), 237 Cicatrization, for pilonidal disease, 105–106 Ciprofloxacin, for perianal abscess and fistula
in Crohn’s disease, 146 Cirrhosis patients, hemorrhoids in, 62 Cloaca, 2–3, 5 Coccygodynia, 246–247 Colonic transit testing, 44– 45, 218 Colostomy
for anorectal malformations, 181–183, 184f for fecal incontinence, 174
Computed tomography (CT) scan
for anorectal abscess, 86–88 for anorectal fistula, 86–
88
for
anorectal
foreign body, 203
for anorectal trauma/injury, 208–209
Constipation, 215
clinical evaluation, 217 functional testing, 217–218 pathophysiology, 216 therapeutic management, 218–224 treatment options for, 222–224
Conventional fistulography, for anorectal
fistula, 85 Corticosteroids, for hemorrhoids, 119 Crohn’s disease (CD)
patients
ARA/ARF treatment in, 95–97 hemorrhoids in, 61
perianal (see Perianal Crohn’s disease, in IBD
patients) Cryosurgical ablation, for pilonidal disease, 110 Cryotherapy, for internal hemorrhoids, 60 Cryptoglandular theory, 81 CT. See Computed tomography (CT) scan Cytomegalovirus (CMV) and infectious
proctitis, 131–132
D
Deep pelvic floor muscles, 14–17, 15–19f
anatomy and function, relationship
between, 19–20
268 Index
Defecatory disorders, 216
treatment options for, 219–222
Defecography, 45, 230–231
for fecal incontinence, 169 for pelvic floor disorders, 153–155
magnetic resonance, 155–156 normal findings, 155 parameters, 154
technique, 154 Delorme operation, 255 Descending perineum syndrome, ultrasound
for, 157–158
Diagnosis, SRUS, 228–231
anorectal function tests, 231 histology, 230 radiology, 230–231
Dietary modification, for internal
hemorrhoids, 41 Digestive system, development of, 2f Digital palpation, 32 Digital rectal examination (DRE)
for anorectal dysfunction, 38–39 for anorectal foreign body, 202–203 clinical utility of, 34–35 components of, 31t protocol, 29–34, 30f
digital palpation, 32 inspection, 32 perineal sensation and anocutaneous
reflex assessments, 32
using maneuvers, 32–34 Diltiazem, for anal fissure, 74 Diosmin, for internal hemorrhoids, 57 Distal colostogram, for anorectal
malformations, 182–183, 182f, 185f
Doppler-guided hemorrhoidal arterial
ligation, for grade II–III hemorrhoids, 59–60
Doxycycline, for gonorrhea, 128
for pelvic floor disorders, 153–155 DRE scoring system (DRESS), 34 DRE. See Digital rectal examination (DRE) DRESS. See DRE scoring system (DRESS) Dynamic graciloplasty, for fecal incontinence,
174
Dyssynergic defecation, 215–217
E
EAS. See External anal sphincter (EAS) EAUS. See Endoanal ultrasound (EAUS) ED. See Evacuatory dysfunction (ED) Electromyography (EMG), for anorectal
disorders, 41
Embryology, of anorectum. See Anorectum,
embryology of Embryonic cell differentiation, 5 EMG. See Electromyography (EMG) Endoanal ultrasonography, 230 Endoanal ultrasound (EAUS), 42
for
anal
fissure, 70–71f for anorectal abscess, 85–86 for anorectal fistula, 85–86, 86–87f, 88 for fecal incontinence, 168, 169f for perianal fistula in Crohn’s disease,
145–146 EndoFLIP, for anorectal disorders, 41 Endoscopic removal, for mendoscopic
removal, 204–205 Endothelin-1, for internal hemorrhoids, 56 Enemas, 223–224 Enterobius vermicularis (pinworms), and
pruritus ani, 120–121 Enterocele, ultrasound for, 157 Evacuation tests, 44–45
balloon expulsion test, 44 colonic transit testing, 44–45 defecography, 45
Evacuatory dysfunction (ED)
anorectal manometry for, 40–41, 40f balloon distension for, 42–43 balloon expulsion test for, 44 colonic transit testing for, 44–45 defecography for, 45 pelvic floor ultrasound for, 42
External anal sphincter (EAS), 9–13, 13f, 41, 156
anal fissure in, 66f endoanal ultrasound for, 42 and fecal incontinence, 162 length-tension function of, 20, 21f muscle fibers of, 12f, 13
External hemorrhoids, 53f
complications of, 55 management of, 55
Index 269
External rectal prolapse surgery, 255, 255f Extramammary Paget disease, 193–194 Extrasphincteric fistula, 83
F
FB. See Foreign body (FB) Fecal incontinence (FI), 29, 34
anorectal manometry for, 39–40 balloon distension for, 42–44 classification of, 161 defined, 9–10, 161 diagnosis of, 164–169
clinical evaluation, 164–165 diagnostic tests, 165–167, 166t, 167f
rectal sensory testing, 168–169, 169f endoanal ultrasound for, 42 etiology of, 9–10 and external anal sphincter, 13 in IBD patients with perianal Crohn’s
disease, 147
pathophysiology of, 162–164, 163t
alterations in stool characteristics, 164
anal sphincter, 162
neurologic alterations, 162–163
pelvic floor muscle injury, 162
sensory alterations, 164 treatment for, 169–175, 170f
minimally invasive treatments, 172–174
noninvasive treatments, 169–172
Fiber-enriched diet, for anal fissure, 72–75 Fiber supplements, for fecal incontinence, 171 Fibrin glue injection
for anorectal abscess, 92 for anorectal fistula, 92
FiLaC. See Fistula-tract laser closure (FiLaC) FI. See Fecal incontinence (FI) Fissure
anal (see Anal fissure) perianal, in Crohn’s disease
clinical features, 141
treatment, 141–142
Fissurectomy, for anal fissure, 76 Fistula
anal, after surgery for anorectal diseases,
253, 254f
anorectal (see Anorectal fistula (ARF))
extrasphincteric, 83 fourchette, 181f intersphincteric, 82–83 perianal, in Crohn’s disease, 142–147
classification of, 143–144, 143–
144t
diagnosis
of,
145 imaging of, 145–146 treatment for, 146–147, 148f
rectovestibular, 179, 180f subcutaneous, 83 suprasphincteric, 83
transphincteric, 82 Fistula-tract laser closure (FiLaC), 95 Fistulectomy
for anorectal abscess, 90
for anorectal fistula, 90 Fistulotomy
anal incontinence and soiling after, 259
for anorectal abscess, 89–90
for anorectal fistula, 90 Flavonoids, for internal hemorrhoids, 57 FLIP. See Functional lumen imaging probe
(FLIP)
Fluorescent Treponemal Antibody Absorption
(FTA-ABS) test, for syphilis, 129 Foley catheter, 42–43 Foregut, 1 Foreign body (FB), anorectal. See Anorectal
foreign body Foscarnet, for CMV proctitis, 132 Fourchette fistula, 181f FTA-ABS. See Fluorescent Treponemal
Antibody Absorption (FTA-ABS) Functional anorectal pain, 238–243
clinical presentation, 240 definition, 238 diagnostic tests, 240–241 epidemiology, 238–239 management, 241–243 pathophysiology, 239–240 predisposing conditions, 239–240
Functional disorders after surgery for anorectal
diseases, 251–256
anal fissure, 253 anal fistulas, 253, 254f external rectal prolapse surgery, 255, 255f
270 Index
hemorrhoids, 251–252, 252–253f imperforate anus surgery, 255, 256f obstructed defecation syndrome, 253–255,
254f
rectal cancer surgery, 256
Functional lumen imaging probe (FLIP), 9–10,
24–25
for anorectal disorders, 41
G
Ganciclovir, for CMV proctitis, 132 Gastrointestinal stromal tumors (GISTs),
195–196
Glyceryl trinitrate (GTN), for anal fissure,
67–75 Gonorrhea, and infectious proctitis, 127–128 Goodsall’s rule, 85 GTN. See Glyceryl trinitrate (GTN)
H
HD-ARM. See High-resolution anorectal
manometry (HD-ARM) Hemorrhoidal disease
classification of, 53, 53f clinical evaluation of, 54–55 external hemorrhoids, complications of, 55 external hemorrhoids, management of, 55 internal hemorrhoids, management of,
55–60
dietary and lifestyle modification, 41 office-based procedures, 60 oral medication, 57 rubber band ligation, 58–60, 59f sclerotherapy, 57–58, 58f topical medication, 56
management in specific considerations,
60–62
cirrhosis and portal hypertension, 62 Crohn’s disease patients, 61 immunocompromised patients, 61 patients taking anticoagulants or
antiplatelet drugs, 60–61
pregnancy, 61 pathophysiology of, 52 prevalence of, 51–52 risk factors of, 51–52
Hemorrhoidectomy, 119
anal incontinence and soiling after, 259 obstructed defecation for anal structure
after, 260
Hemorrhoids
in perianal Crohn’s disease patients, 140 and pruritus ani, 118–119 after surgery for anorectal diseases, 251 –252,
252–253f
Herpes simplex virus (HSV ) and infectious
proctitis, 125–127, 127f Hesperidin, for internal hemorrhoids, 57 High-resolution anorectal manometry
(HD-ARM), for evacuatory dysfunction,
40–41 Hig
h-resolution
anorectal manometry
(HR-ARM), 24–25, 24f Hindgut, 1
embryology of, 2–3, 4f theories on development of, 3–6
HIV. See Human immunodeficiency virus
(HIV) HMO system, 156 HR-ARM. See High-resolution anorectal
manometry (HR-ARM) HSIL, 191 HSV. See Herpes simplex virus (HSV ) Human immunodeficiency virus (HIV ) and
anal fissure, 77 Humans, anal-closure mechanism in
anatomy and function assessment of,
21–23, 23f
I
IAS. See Internal anal sphincter (IAS) IBD. See Inflammatory bowel disease (IBD) Idiopathic pruritus ani, 116 Ileostomy, for fecal incontinence, 174 Immunocompromised patients, hemorrhoids
in, 61 Imperforate anus surgery, 255, 256f Infections, and pruritus ani, 120–121 Infectious proctitis
amebiasis, 132–133 causes of, 126t cytomegalovirus and, 131–132
Index 271
Infectious proctitis (Continued)
defined, 125 gonorrhea and, 127–128 herpes simplex virus and, 125–127, 127f lymphogranuloma venereum and, 130–131 non-LGV chlamydia and, 130 syphilis and, 128–130, 129f
Inflammatory bowel disease (IBD)
and anal fissure, 77 anorectal abscess and, 81 anorectal fistula and, 81, 89 patients, perianal Crohn’s disease in
(see Perianal Crohn’s disease, in IBD patients)
Infliximab, for perianal abscess and fistula in
Crohn’s disease, 146
Infrared coagulation, for internal
hemorrhoids, 60 Ingested foreign body, 207 Internal anal sphincter (IAS), 10–11, 10f, 156
anal fissure in, 65, 66f, 67, 74 endoanal ultrasound for, 42 and facal incontinence, 162 neural control of, 11
Internal hemorrhoids, 53, 53f
grades of, 54f management of, 55–60
dietary and lifestyle modification, 56 oral medication, 57 rubber band ligation, 58–60, 59f sclerotherapy, 57–58, 58f topical medication, 56
International Anorectal Physiology Working
Group (IAPWG), 218 Intersphincteric fistula, 82–83 Intersphincteric injections, for fecal
incontinence, 173–174 Intussusception
obstructed defecation after stapled
hemorrhoidopexy or STARR operation
for, 260
rectal mucosal, assessment using
maneuvers, 33–34
rectal, ultrasound for, 156
ISDN. See Isosorbide dinitrate (ISDN)
Isosorbide dinitrate (ISDN), for anal
fissure, 74
Itchy anus. See Pruritus ani
K
Karydakis technique, 106, 107f
L
LARS. See Low anterior resection syndrome
(LARS) LAS. See Levator ani syndrome (LAS) Laser ablation
for anorectal abscess, 95
for anorectal fistula, 95 Laser depilation, for pilonidal disease, 110 Laser therapy, for internal hemorrhoids, 60 Lateral internal sphincterotomy (LIS)
for anal fissure, 67–72, 74–76
anal incontinence and soiling after, 259 Laxatives, for anal fissure, 72–75 Length-tension
function,
of EAS and PRM, 20,
21f
Levator ani syndrome (LAS), 14–17, 15–19f, 238
anatomy and function, relationship
between, 19–20 LGV. See Lymphogranuloma venereum (LGV) Lidamidine, for fecal incontinence, 171 Lifestyle modification, for internal
hemorrhoids, 56 LIFT. See Ligation of intersphincteric fistula
tract (LIFT) Ligation of intersphincteric fistula tract (LIFT)
for anorectal abscess, 93
for anorectal fistula, 93 Limberg flap technique, 109 Liquid paraffin (mineral oil), 223 LIS. See lateral internal sphincterotomy (LIS) Loperamide, for fecal incontinence, 171 Low anterior resection syndrome (LARS), 256,
260 Lues, and anal fissure, 77 Lumbosacral spine X-ray, for anorectal
malformations, 182 Lymphogranuloma venereum (LGV ) and
infectious proctitis, 130–131 Lymphoid tissue, 195
272 Index
M
Magnetic anal sphincter (Fenix), for fecal
incontinence, 175
Magnetic resonance diffusion tensor imaging
(MRDTI), of external anal sphincter, 12–13, 14f
Magnetic resonance imaging (MRI)
for anal sphincter, 42 for anorectal abscess, 86–88 for anorectal fistula, 86–88 for fecal incontinence, 169 for perianal fistula in Crohn’s disease,
145–146 Malone procedure, for fecal incontinence, 173 Maneuvers
anorectal function assessment using, 32–33 anorectal pain assessment using, 33–34 rectal mucosal intussusception assessment
using, 33–34
rectocele assessment using, 33–34
Marsupialization, for pilonidal disease,
105–106, 106f MDSCs. See muscle-derived stem cells
(MDSCs) Mebendazole, for pinworm pruritus, 121 6-Mercaptopurine, for perianal abscess and
fistula in Crohn’s disease, 146 Mesenchymal stem cells (MSCs), 94
local injection of, for perianal abscess and
fistula in Crohn’s disease, 147 Mesoderm, 1–3 Metronidazole
for amebiasis, 133 for perianal abscess and fistula in Crohn’s
disease, 146 Micro CT imaging, of external anal sphincter,
12–13 Midgut, 1 Minimally invasive transanal removal,
anorectal foreign body, 205 Mixed hemorrhoids, 53f MLCK. See Myosin light chain through a kinase
(MLCK) Motor-evoked potentials (MEPs)
anal, 42
translumbar, 42 transsacral, 42
Motor function tests, for anorectal disorders,
39–44
translumbar MEPs, 42 MRD. See MRI defecography (MRD) MRDTI. See Magnetic resonance diffusion
tensor imaging (MRDTI)
MRI defecography (MRD), 45
or pelvic floor disorders, 155–156
parameters and normal findings, 155–156
technique, 155 MRI. See Magnetic resonance imaging (MRI) MSCs. See Mesenchymal stem cells (MSCs) Mucosal advancement flap, 91–92, 92f Muscle-derived stem cells (MDSCs), for fecal
incontinence,
175
M
yGiHealth, 9–10
Myosin light chain through a kinase
(MLCK), 10–11
N
NAATs. See Nucleic acid amplification tests
(NAATs) Neural control of internal anal sphincter, 11 Neurogenic itch, 115 Neuropathic itch, 115 Nifedipine, for anal fissure, 74 Nitrates, for anal fissure, 72 Nitroglycerine (NTG), 76 Non-LGV chlamydia, for syphilis, 130 NTG. See nitroglycerine (NTG) Nucleic acid amplification tests (NAATs), for
gonorrhea, 128–131
O
OASIS. See Obstetric anal sphincter injuries
(OASIS) Obstetric anal sphincter injuries (OASIS), 42 Obstructed defecation
for anal structure after hemorroidectomy,
260
after stapled hemorrhoidopexy or STARR
operation for rectocele/
intussusception, 260
Index 273
Obstructed defecation syndrome, after surgery
for anorectal diseases, 253–255, 254f
Operative removal, of anorectal foreign body,
205–206 Opioid-induced constipation, 223 Oral medication, for internal hemorrhoids, 57 Osmotic laxatives, 222–223 Overlapping sphincteroplasty, for fecal
incontinence, 174 Over-the-scope-clip
for anorectal abscess, 94–95 for anorectal fistula, 94–95
P
Parks classification, of perianal fistula, 143,
143t Paromomycin, for amebiasis, 133 PCDAI. See Perianal Crohn’s Disease Activity
Index (PCDAI) PCL. See Pubococcygeal line (PCL) Pelvic floor disorders, imaging of
defecography, 153–155
normal findings, 155 parameters, 154 technique, 154
MR defecography, 155–156
parameters and normal findings, 155–156 technique, 155
ultrasound, 156
descending perineum syndrome, 157–158 enterocele and sigmoidocele, 157 intussusception and rectal prolapse, 156,
157f
rectocele, 157, 158f spastic pelvic floor syndrome, 158
Pelvic floor muscle injury, and fecal
incontinence, 162 Pelvic floor therapy, for anal fissure, 72–75, 73f Pelvic floor ultrasound, for anorectal disorders,
42 Pen˜a, Alberto, 179 Perianal Crohn’s Disease Activity Index
(PCDAI), 145t Perianal Crohn’s disease, in IBD patients
classification of, 138–149
abscess, 142–147 Cardiff classification, 139t complications after restorative
proctocolectomy, 147–149 fecal incontinence, 147 fissures, 141–142 fistula, 142–147, 143–144t hemorrhoids, 140 skin tags, 139–140 stricture, 142 ulcerations, 140–141
complications of, 138 diagnosis of, 138 epidemiology of, 137–
138
manifestations,
137
P
erianal eczema/rash, 194 Perianal injury, 209–210 Perianal skin tag, 53 Perineal sensation assessment, 32 Petrolatum ointment, for pruritus ani, 117 Pharynx (phar yngeal gut), 1 Phenylephrine
for fecal incontinence, 171 for internal hemorrhoids, 56
Pilonidal disease
clinical manifestations of, 102 complications of, 103 differential diagnosis of, 102 etiology of, 101–102 incidence of, 101 pathologic anatomy of, 103 postoperative care of, 111 surgical treatment for, 104–111
biologic sealant, 111 conservative management, 110 cryosurgical ablation, 110 cutting seton, 111 excision and primary course, 106–107,
107f
excision and rotation flap, 108–110,
108–109f
excision with open wound, 104–105,
105f incision and curettage, 105, 105f laser depilation, 110
274 Index